Clinical Trial Update: Targeting Inter-Hemispheric Alpha Coherence With tACS To Treat PMDD [NA]

View source ↗

Summary

A terminated clinical trial investigating transcranial alternating current stimulation (tACS) to target inter-hemispheric alpha coherence for Premenstrual Dysph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Dysphoric Disorder

Drugs mentioned

• tACS

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Premenstrual Dysphoric Disorder | NA | Status: TERMINATED | Results posted: 2020-10-09